Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学IBD and Cancer Risk, Clinical Trials

Brian Feagan

MD, FRCPC

🏢Western University / Alimentiv🌐Canada

Professor of Medicine, Senior Scientific Director

120
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Brian Feagan is a leader in IBD clinical trials and led pivotal studies of vedolizumab, ustekinumab, and other biologics in Crohn disease and ulcerative colitis. He established modern trial endpoints including mucosal healing and histologic remission. His work shaped evidence base for IBD therapies that affect long-term cancer risk.

Share:

🧪Research Fields 研究领域

IBD clinical trials
vedolizumab
ustekinumab IBD
trial endpoints IBD
mucosal healing

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Brian Feagan 的研究动态

Follow Brian Feagan's research updates

留下邮箱,当我们发布与 Brian Feagan(Western University / Alimentiv)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment